Small businesses in the research and development domain will have the opportunity to engage with the DHS Small Business Innovation Research program representatives beginning August 20, in the final leg of a National Road Tour sponsored by the Small Business Administration.
Transgender individuals may be at higher risk for heart disease, according to a review article published by Michael S. Irwig, MD, associate professor of medicine at the George Washington University School of Medicine and Health Sciences, in Reviews in Endocrine and Metabolic Disorders.
Today the Smithsonian released its third installment of Second Opinion: “The State of the Arts in 21st-Century America,” which examines the importance, impact and future of the arts in America. Launched in 2017, Second Opinion is a digital platform that convenes thought leaders to explore some of the critical issues facing our nation and the world.
AACC welcomed thousands of medical professionals and healthcare leaders at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo from July 29–August 2. The meeting showcased advancements in clinical testing technology and research that improve the ability of healthcare providers to diagnose patients quickly and accurately and ensure that patients get effective medical treatment.
Announcement of a New IFCC Division
Introduction to Traceability in laboratory medicine (TLM) and Joint IFCC and JCTLM initiatives in this area
Technology innovators are invited to an industry Stakeholder Summit, August 9 in Washington, DC, to learn about the highest priority needs of more than 7.5 million first responders in the global market.
The George Washington University (GW) Health Workforce Institute, based at the Milken Institute School of Public Health (Milken Institute SPH), today announced that its Leaders for Health Equity Fellowship program has officially joined the global community of Atlantic Fellows. The program will now be known as the Atlantic Fellows for Health Equity.
Announcement of next IFCC EuroMedLab and WorldLab Congresses
As the national opioid epidemic continues to take its toll, the 126th Annual Convention of the American Psychological Association will include a variety of sessions focused on how psychologists can help people with opioid dependence and addiction. Following is a list of relevant sessions.
Violence will be a featured topic at the 126th Annual Convention of the American Psychological Association, with psychologists discussing community violence, gender-based violence, the role of race/ethnicity in the study of violence, intimate partner violence and the role of masculinity its perpetration. Following is a list of relevant sessions.
U.S. suicide rates are on the rise, with nearly 45,000 Americans dying by their own hand each year. Suicide is now the 10th leading cause of death in the United States, and recent suicides by celebrities Robin Williams, Anthony Bourdain and Kate Spade have made international headlines.
With the issue of immigration featured prominently in the news, psychologists at the 126th Annual Convention of the American Psychological Association will be discussing many aspects of the topic, including the psychological harm to migrant youth in detention facilities and how psychologists are responding to the needs of immigrant communities. Following is a list of relevant sessions.
WASHINGTON — Georgetown University professors offer expertise for journalists seeking interviews in a variety of subjects related to Ebola. Topics include infectious disease control and treatment, vaccine development, clinical trials, global health security, and international health regulations. To schedule an interview, please contact Karen Teber at km463@georgetown.
A U.S.-based survey of women with polycystic ovary syndrome (PCOS), a common condition characterized by reproductive and metabolic problems, points to distrust and lack of social support from healthcare providers as major contributing factors in their negative medical care experiences, according to a new study published in the Endocrine Society’s Journal of the Endocrine Society.
IMV, part of the Science and Medicine Group, the leading market research and business intelligence provider to the laboratory diagnostic industry, announced the category winners of the 2018 IMV ServiceTrak™ awards in clinical analyzers. Sysmex America, Inc. was recognized for: Hematology: •Best System Performance •Best Customer Satisfaction •Best Service
AACC announced today the launch of a new credential for point-of-care testing professionals. This new certification – the first of its kind in the United States -- is designed for healthcare experts who perform diagnostic tests outside the central laboratory.
On August 9, 2018, the Department of Homeland Security’s Science and Technology Directorate (S&T) will host an International Forum to Advance First Responder Innovation (IFAFRI) Stakeholder Summit.
For decades, microbiologists have done their work by hand even as robotics and automation began to improve other laboratory processes. Until recently, the delicate techniques necessary to introduce mechanisms to microorganism study and analysis have been challenging for these divisions to automate. Now that's changing.
ARUP recently rolled out a next generation UM dashboard for clients—hospitals and healthcare organizations—that will allow them to further mine this data and make it actionable.
Ortho Clinical Diagnostics announced that, for the third year in a row, the Ortho Care™ service and support program was the highest-ranked original equipment manufacturer for overall service performance in the diagnostics industry.
Scientists have discovered that in rheumatoid arthritis (RA) patients, lower levels of vitamin D are associated with increased disease severity. Their findings, announced today at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo, indicate that vitamin D supplementation could significantly improve quality of life for RA patients.
Researchers have developed a novel test that rapidly distinguishes between type 1 and type 2 diabetes. This new method and a second study revealing gaps in care for women with gestational diabetes were presented today at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo, and could improve treatment for patients with all diabetes types across the board.
Research announced today at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo reveals that two out of three of the digital home ovulation tests sold by U.S. retailers do not accurately predict when a woman is ovulating. This information is critical for women trying to get pregnant and could improve their chances by helping them to better select at-home tests to guide intercourse timing.
Recent tests integrating commercial and government capabilities is making tactical communications between international and interagency law enforcement operators safer and more reliable.
AACC is pleased to announce the recipients of the AACC 2018 Top Corporate Supporter Awards. This year, AACC recognizes 47 different companies and organizations that generously support the association through sponsorships, advertising, and exhibiting. These significant contributions make it possible for AACC to improve patient care by fostering research, innovation, and professional excellence in the field of laboratory medicine.
Performance Motion Devices today announced that its ATLAS® digital amplifiers, featuring the highest power density in the industry, can now be used with third party microprocessors or field programmable gate arrays (FPGAs) via Serial Peripheral Interface (SPI) communications.
Today biotech innovators will present portable tests that could help more patients get accurate diagnoses in a competition to win AACC’s Disruptive Technology Award.
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced that its VITROS Immunodiagnostic Products HIV Combo Reagent Pack and Calibrator (VITROS® HIV Combo test) received approval from the U.S. Food and Drug Administration for use on Ortho’s VITROS 3600 Immunodiagnostic System
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced it was selected for a gold-level Edison Award™ in the Best New Product Awards™ category for its VITROS® NEPHROCHECK® Test
Ortho Clinical Diagnostics received approval from the U.S. Food and Drug Administration for Ortho’s VITROS® Immunodiagnostic Products HBeAg Assay and the VITROS® Immunodiagnostic Products Anti-HBe Assay for use on the VITROS® 3600 Immunodiagnostic System and VITROS® 5600 Integrated System
Ortho Clinical Diagnostics announced that its VITROS® NEPHROCHECK® test received CE Mark. The VITROS® NEPHROCHECK® test is the first fully automated risk assessment tool for predicting Acute Kidney Injury (AKI), a serious and potentially fatal condition affecting hospital patients worldwide
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced an international distribution and co-promotion agreement with Thermo Fisher Scientific to provide 14 assays used to monitor therapeutic drugs, immunosuppressive drugs and drugs of abuse.
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced it will officially unveil the VITROS® XT 7600 Integrated System, now available in numerous countries that accept CE Mark, at the 2018 AACC Annual Scientific Meeting & Clinical Lab Expo
The U.S. Department of Energy announced $10 million in funding for 13 projects that will enhance sophisticated computer models for understanding weather and climate patterns.
James Kim, a toxicologist with extensive scientific and research experience in the public, private and academic sectors, has joined the American Cleaning Institute (ACI) as Associate Vice President, Science & Regulatory Affairs. Dr. Kim most recently served as toxicologist with the Office of Management and Budget’s (OMB) Office of Information and Regulatory Affairs (OIRA), Statistical and Science Policy Branch. OMB is part of the Executive Office of the President.
Sysmex, one of the fastest growing providers of diagnostic hardware and software in the U.S., celebrates its 50th anniversary in booth number 1231 at this year’s annual meeting of the American Association for Clinical Chemistry (AACC). The company is also sharing its plans to equip the clinical laboratory of the future with innovative solutions in flow cytometry, urinalysis and hematology.
Responding to customer requirements to handle increased volumes in decentralized clinical testing, MedTest Dx today announced the introduction of its BA-800M Clinical Analyzer for general chemistry with a full line of reagents and the launch of its BC-5390 5-Part Differential Hematology Analyzer at the 2018 American Association for Clinical Chemistry (AACC) Annual Scientific Meeting.
Fujirebio Diagnostics, Inc., a consolidated subsidiary of Miraca Holdings Inc., has received U.S. Food and Drug Administration (FDA) clearance of the company’s Lumipulse® G B•R•A•H•M•S PCT Assay for testing on its LUMIPULSE® G1200 immunoassay platform.
Fujirebio Inc., a consolidated subsidiary of Miraca Holdings Inc., (Head office: Shinjuku-ku, Tokyo, President and CEO: Yoshihiro Ashihara, hereinafter “Fujirebio” or “the Company”) announced today that it has entered into an agreement with US-based Janssen Pharmaceuticals, Inc. (hereinafter “Janssen”) to develop and commercialize an AMYLOID β 42/40 RATIO assay.
MedTest Holdings, the solution provider of choice offering integrated products and services for decentralized clinical diagnostic testing, today announced the debut of its new corporate name—MedTest Dx—at the upcoming 2018 American Association for Clinical Chemistry (AACC) Annual Scientific Meeting.
Debra Harrsch, founder and chief executive of Brandwidth Solutions, a full-service marketing agency addressing science-based businesses, received a Management Consulting Award from CEO Today magazine. The international publication “identifies the most hard-working and outstanding consultancy experts across the globe.”
Brandwidth Solutions, LLC, a full-service marketing agency addressing science-based businesses, has been recognized as Best Specialist Life Science Marketing Agency 2018-Pennsylvania by AI Global Media.
SCIEX, a global leader in life science analytical technologies, advanced the accessibility of mass spectrometry in the clinical setting with new product introductions at AACC 2018. Today, SCIEX announced the launch of the new Topaz™ Prep Station, an automated sample preparation workstation that is ideal for labs managing high daily sample volumes, as well as the new automated Vitamin D 200A Assay Kit.
Hahn-Schickard enables complex clinical pictures to be diagnosed quickly and reliably directly at the point of care. The latest device generation allows the amplification of RNA and DNA by means of fast PCR in 20 - 25 minutes. This makes it possible, for example, to analyze a real patient sample fully automatically in 30 minutes. The device can also be used in the field of food analysis or environmental analysis.
At the 70th AACC Annual Scientific Meeting & Clinical Lab Expo—the premier global conference and exhibit for laboratory medicine—trailblazers in the field will share the pioneering research and technology paving the way for better clinical testing and patient care. From July 29–August 2 in Chicago, the meeting will feature more than 200 talks on a broad range of timely healthcare topics.
PixCell is a cell based diagnostics company that has developed the HemoScreen: the first true Point of Care (POC) Hematology analyzer that uses a self-contained disposable cartridge, preventing the need for any maintenance or calibrations. The HemoScreen is a portable and user-friendly test device that provides lab accurate results for the standard 20 Complete Blood Count (CBC) parameters, including a 5-part differential.
NAMSA®, the world’s only Medical Research Organization (MRO) that accelerates medical device development through integrated laboratory testing, clinical research and regulatory consulting services, announced today the launch of its in vitro diagnostic (IVD) development business to provide global manufacturers a proven resource for expedited commercialization outcomes delivered via NAMSA’s “Uniquely IVD” regulatory, quality and clinical research services.
Equitech Enterprises Inc. is leading supplier of quality human blood, human blood components, and biological fluids to the research industry.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right